Lastest Insider Transactions Of Monte Rosa Therapeutics, Inc. ( GLUE ) |
Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
GLUE | Monte Rosa Therapeutics, Inc. | Leo Chandra P. | Directior | 2025-03-24 | Buy | 10,000 | 5.84 | 58,383 | 2025-03-25 18:32:00 |
GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | 2024-10-28 | Sell | 157,895 | 9.44 | 1,491,041 | 2024-10-30 16:35:43 |
GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | 2024-09-20 | Sell | 1,132,566 | 6.53 | 7,395,203 | 2024-09-24 16:40:59 |
GLUE | Monte Rosa Therapeutics, Inc. | Versant Venture Capital VI, L.P. | 10% Owner | 2024-09-11 | Sell | 567,213 | 6.00 | 3,404,791 | 2024-09-13 18:44:19 |
GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2024-07-05 | Sell | 1,610 | 3.83 | 6,166 | 2024-07-09 16:15:03 |
GLUE | Monte Rosa Therapeutics, Inc. | Dunn Edmund | Principal Accounting Officer | 2024-06-03 | Sell | 1,207 | 4.04 | 4,876 | 2024-06-05 16:10:07 |